We are looking for bright, motivated people who are passionate about changing the lives of cancer patients using their wet lab skills and wish to grow into translational oncology leaders!
The Ghobrial Lab in Boston, headed by Dr. Irene Ghobrial, MD, Professor of Medicine, (https://connects.catalyst.harvard.edu/Profiles/display/Person/75208), is affiliated with Harvard Medical School, Dana-Farber Cancer Institute, and the Broad Institute, and is seeking to hire a full-time postdoctoral research fellow (MD, PhD or MD/PhD) to study disease progression and therapeutic response/resistance in patients with Multiple Myeloma and its precursor conditions, Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma. The Ghobrial lab (https://ghobriallab.dana-farber.org/) comprises clinicians and scientists who work on bulk and single-cell sequencing of tumors and their microenvironment (DNA, RNA, protein, epigenetics), as well as liquid biopsy, functional genomics, drug development and computational biology. Our science is conducted in close collaboration with Irene’s clinical team, that is in charge of caring for patients and conducting multiple clinical trials. Irene and a team of collaborators have recently received the prestigious Stand Up 2 Cancer Dream Team award (https://standuptocancer.org/research/research-portfolio/dream-teams/precursor-myeloma-dream-team/), which will allow us to screen 50,000 individuals at high risk for developing multiple myeloma, in the largest US population study on myeloma precursors to date.
Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
You will have collaborations with clinicians, basic and translational scientists (wet and dry lab), working together to improve our understanding of myeloma biology, discover new therapeutic targets, and identify ways to prevent progression from MGUS/SMM to overt myeloma. Ideal candidates will have an MD or PhD in Cancer Biology, Biochemistry, Bioengineering or another relevant discipline with an interest in developing computational biology skills and conducting translational research to improve outcomes for cancer patients. Furthermore, they should have excellent communication skills and initiative, and be excited by growing and learning across a broad range of disciplines. The Ghobrial lab is the perfect fit for someone who enjoys multi-tasking in science and seeks to take on more responsibilities and grow into a leader.
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.Apply